Internalized FGF-2-Loaded Nanoparticles Increase Nuclear ERK1/2 Content and Result in Lung Cancer Cell Death

Innovative cancer treatments, which improve adjuvant therapy and reduce adverse events, are desperately needed. Nanoparticles provide controlled intracellular biomolecule delivery in the absence of activating external cell surface receptors. Prior reports suggest that intracrine signaling, following...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Tianxin, Little, Andrew C., Aronshtam, Alexander, Marquis, Taylor, Fenn, Spencer L., Hristova, Milena, Krementsov, Dimitry N., van der Vliet, Albert, Spees, Jeffrey L., Oldinski, Rachael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221911/
https://www.ncbi.nlm.nih.gov/pubmed/32230722
http://dx.doi.org/10.3390/nano10040612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221911/
https://www.ncbi.nlm.nih.gov/pubmed/32230722
http://dx.doi.org/10.3390/nano10040612

Ejemplares similares